BiosimCovex is a COVID-19 Nosode that has undergone extensive research work. Three variants of COVID-19 Nosode were prepared by our team of scientists. This published research article gives technical details.
Preparation of Coronavirus nosodes sourced from a clinical sample of SARS-Cov-2 positive patient inactivated strain and spike glycoprotein.
BiosimCovex has undergone safety and efficacy trials. It has shown safety in the animal trials (following OECD guidelines), Phase 1 human trials in healthy human volunteers as well as in clinical trials. The studies have shown impressive safety and efficacy in placebo-controlled, randomized trials.